Digital therapeutics industry looks to move past Pear’s bankruptcy

As it moves past Pear Therapeutics’ downfall, the digital therapeutics industry is looking for a pathway to regulatory reimbursement and focusing on non-prescription products. 

Pear Therapeutics, which had been one of the most notable companies in the digital therapeutics industry, was forced to declared bankruptcy in April and subsequently sold off its assets in May. Michael Pace, founder and CEO of PalmHealthco, which advises digital…